A large retrospective cohort study found that GLP-1 receptor agonist use was associated with a lower risk of tuberculosis in people with type 2 diabetes compared with sulfonylureas, metformin, DPP-4 ...
VPM1002 is a live recombinant vaccine created by genetically modifying BCG. It was originally developed in Germany and ...
A novel tuberculosis (TB) vaccine candidate failed to match the standard bacillus Calmette-Guerin (BCG) vaccine in preventing ...
Pune: A large-scale tuberculosis survey in Pune has exposed a worrying problem in India’s fight against the disease, detecting recurrent TB in several survivors. In most of these cases, symptoms were ...
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating ...
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating ...
Tuberculosis (TB), one of the leading bacterial infections worldwide, is caused by the Mycobacterium tuberculosis complex ...
Orsini, a leader in rare disease pharmacy solutions, announced today that it is a specialty pharmacy partner for Priovant’s LISRAYA™ (brepocitinib), a once-daily oral therapy for the treatment of ...
Prescription drug costs have changed considerably for Medicare beneficiaries over the last few years. Case in point? The introduction of a federal cap on annual out-of-pocket Medicare Part D spending ...